✦ LIBER ✦

Prostate-specific antigen half-life: a new predictor of progression-free survival and overall survival in Chinese prostate cancer patients

✍ Scribed by Lin, Guo-Wen; Yao, Xu-Dong; Zhang, Shi-Lin; Dai, Bo; Ma, Chun-Guang; Zhang, Hai-Liang; Shen, Yi-Jun; Zhu, Yao; Zhu, Yi-Ping; Shi, Guo-Hai

Book ID: 109832332
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 423 KB
Volume: 11
Category: Article
ISSN: 1008-682X
DOI: 10.1038/aja.2008.36

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer-specific survival and predictors

Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy

✍ Fernando P. Secin; Fernando J. Bianco Jr.; Andrew J. Vickers; Victor Reuter; Tho 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB 👁 1 views

## Abstract ## BACKGROUND The objectives of the current study were to determine the long‐term biochemical recurrence (BCR) and cancer‐specific survival (CSS) rates for men with seminal vesicle invasion (SVI) and to identify risk factors for freedom from BCR and CSS in patients who received treatme

Clinical utility of the percentage of po

Clinical utility of the percentage of positive prostate biopsies in predicting prostate cancer-specific and overall survival after radiotherapy for patients with localized prostate cancer

✍ Anthony V D’Amico; Aparna Keshaviah; Judith Manola; Kerri Cote; Marian Loffredo; 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 128 KB

Prostate-specific antigen relapse-free s

Prostate-specific antigen relapse-free survival and side-effects in 734 patients with up to 10 years of follow-up with localized prostate cancer treated by permanent 125iodine implants

✍ Pedro J. Prada; Germán Juan; Herminio González-Suárez; José Fernández; Isabel Ji 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 247 KB

Incidence of positive pelvic lymph nodes

Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of ≤10 ng/mL and biopsy Gleason score of ≤6, and their influence on PSA progression-free survival after radical prostatectomy

✍ DOROTHEA WECKERMANN; MARCUS GOPPELT; ROBERT DORN; FRIEDHELM WAWROSCHEK; ROLF HAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Comparison of prostate-specific antigen

Comparison of prostate-specific antigen recurrence-free survival in a contemporary cohort of patients undergoing either radical retropubic or robot-assisted laparoscopic radical prostatectomy

✍ Florian R. Schroeck; Leon Sun; Stephen J. Freedland; David M. Albala; Vladimir M 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB